- Home
- EXEL vs WAL Comparison
EXEL vs WAL Comparison
Compare EXEL & WAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EXEL
- WAL
- Stock Information
- Founded
- EXEL 1994
- WAL 1994
- Country
- EXEL United States
- WAL United States
- Employees
- EXEL N/A
- WAL N/A
- Industry
- EXEL Biotechnology: Biological Products (No Diagnostic Substances)
- WAL Major Banks
- Sector
- EXEL Health Care
- WAL Finance
- Exchange
- EXEL Nasdaq
- WAL Nasdaq
- Market Cap
- EXEL 10.4B
- WAL 10.1B
- IPO Year
- EXEL 2000
- WAL 2005
- Fundamental
- Price
- EXEL $37.88
- WAL $90.68
- Analyst Decision
- EXEL Buy
- WAL Strong Buy
- Analyst Count
- EXEL 21
- WAL 13
- Target Price
- EXEL $43.65
- WAL $97.62
- AVG Volume (30 Days)
- EXEL 2.4M
- WAL 946.3K
- Earning Date
- EXEL 10-28-2025
- WAL 10-16-2025
- Dividend Yield
- EXEL N/A
- WAL 1.68%
- EPS Growth
- EXEL 81.76
- WAL 14.60
- EPS
- EXEL 2.08
- WAL 7.61
- Revenue
- EXEL $2,230,005,000.00
- WAL $3,120,700,000.00
- Revenue This Year
- EXEL $9.24
- WAL $14.78
- Revenue Next Year
- EXEL $13.04
- WAL $10.40
- P/E Ratio
- EXEL $18.24
- WAL $11.91
- Revenue Growth
- EXEL 10.73
- WAL 10.46
- 52 Week Low
- EXEL $25.12
- WAL $57.05
- 52 Week High
- EXEL $49.62
- WAL $98.10
- Technical
- Relative Strength Index (RSI)
- EXEL 44.99
- WAL 67.34
- Support Level
- EXEL $36.23
- WAL $87.11
- Resistance Level
- EXEL $38.95
- WAL $89.99
- Average True Range (ATR)
- EXEL 0.85
- WAL 2.10
- MACD
- EXEL 0.13
- WAL 0.54
- Stochastic Oscillator
- EXEL 60.66
- WAL 78.39
About EXEL Exelixis Inc.
Exelixis Inc is a biopharmaceutical firm that discovers, develops, and commercializes treatments for cancer. Its molecule, cabozantinib, is indicated for the treatment of patients with metastatic medullary thyroid cancer under the name Cometriq and for the treatment of kidney and liver cancer under the name Cabometyx. Exelixis and its partner Roche have also brought Cotellic to market for the treatment of melanoma.
About WAL Western Alliance Bancorporation (DE)
Western Alliance Bancorporation is a Las Vegas-based holding company with regional banks operating in Nevada, Arizona, and California. The bank offers retail banking services and focuses on mortgages for retail customers and commercial loans. The company's reportable segments are Commercial segment includes provides commercial banking and treasury management products and services to small and middle-market businesses, specialized banking services to sophisticated commercial institutions and investors within niche industries, as well as financial services to the real estate industry. Consumer Related segment offers both commercial banking services to enterprises in consumer-related sectors and consumer banking services, such as residential mortgage banking and Corporate & Other.